Group | Treatment | RNA source | No. of mice | CV (percentage) |
---|---|---|---|---|
DBA/1_NC | None | LN from naive control DBA/1 | 3 | 22.8 |
DBA/1_PI | CFA + collagen II | LN from DBA/1 at day 10 after immunisation | 3 | 20.4 |
DBA/1_OA | CFA + collagen II | LN from DBA/1 mice at day 35 after immunisation | 3 | 21.7 |
DBA/1_CA | CFA + collagen II | LN from DBA/1 mice at day 95 after immunisation | 3 | 25.8 |
FVB/N_NC | None | LN from naive control FVB/N | 3 | 21.1 |
FVB/N_PI | CFA + collagen II | LN from FVB/N at day 10 after immunisation | 3 | 22.6 |
FVB/N_OA | CFA + collagen II | LN from FVB/N mice at day 35 after immunisation | 3 | 18.4 |
FVB/N_CA | CFA + collagen II | LN from FVB/N mice at day 95 after immunisation | 3 | 21.1 |